Related Experiment Video

Updated: Jul 3, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

Erlotinib in a patient with acute myelogenous leukemia and concomitant non-small-cell lung cancer

Vincenzo Pitini1, Carmela Arrigo, Giuseppe Altavilla

  • 1Department of Medical Oncology, University of Messina, Messina, Italy.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|July 22, 2008
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos